FDA approves ALS treatment despite questions about efficacy

FDA approves ALS treatment despite questions about efficacy
September 29, 2022
Leonard Cole, who ran secret army germ tests, dies aged 89
September 29, 2022

[ad_1]

The drug is safe, and one study found it may prolong survival and slow paralysis in functions like muscle control and speech. A larger trial will be completed in 2024.

[ad_2]

Source link

Leave a Reply

FDA approves ALS treatment despite questions about efficacy
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more